Delcath Systems Reports Q3 Earnings Beat with Significant Revenue Growth Driven by HEPZATO KIT
Delcath Systems (NASDAQ: DCTH) reported third-quarter financial results that significantly exceeded market expectations. The company posted a GAAP earnings per share (EPS) of $0.17, surpassing estimates by $0.25, and recorded revenue of $35.1 million, which beat projections by $9.26 million. The primary driver for the growth was the HEPZATO KIT, which generated $32.7 million in revenue, a substantial increase from the $19.3 million reported in the same period last year. This represents a 70.7% year-over-year increase in total company revenue, signaling strong commercial adoption of its core product line.
Tickers: $DCTH